Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
3
×
life sciences
national
3
×
national blog main
pfizer
3
×
abbvie
alzheimer's disease
amgen
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
cystic fibrosis
deals
detroit blog main
detroit top stories
diagnostics
gilead sciences
indiana blog main
indiana top stories
merck
national top stories
new york blog main
new york top stories
novartis
raleigh-durham blog main
raleigh-durham top stories
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
startups
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
adverum biotechnologies
albert bourla
What
ceo
3
×
drug
acquisitions
biggest
bio
pfizer
roundup
albert
alex
announced
bourla
build
buy
collaboration
company
company’s
crispr
daniel
debut
discovery
dyne’s
entered
future
gilead
imports
insilico
maker
maps
measured
medicine
microbiome
moves
openly
o’day
patients
pfizer’s
pipeline
research
revenue
sciences
Language
unset
unknown
Current search:
national
×
biotech
×
pfizer
×
ceo
×
@xconomy.com
3 years ago
Bio Roundup: SeaGen Scores, Dyne’s Debut, Microbiome Moves & More
@xconomy.com
4 years ago
Pfizer Taps Insilico Medicine to Use AI for Drug Target Discovery
@xconomy.com
4 years ago
Bio Roundup: Pfizer’s Future, CRISPR in Patients, Drug Imports & More